BRAIN Act of 2021

Summary

Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021 This bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence. The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system. The FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 30 September 2021

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 30 September 2021

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 30 September 2021

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.